SACS Medical is granted FDA clearance

LinkMed’s portfolio company SACS Medical has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for sales of its systems in the U.S.

”FDA clearance is a stamp of quality that will facilitate us in our search for an industrial partner for SACS Medical,” says Ingemar Lagerlöf, CEO, LinkMed.

The clearance is for SACS Medical’s system for medical signal handling, which can handle EEG and EMG signals, among others. The system is used by specialist clinics to diagnose, monitor and treat patients spread over a large geographical area from one centralized location. 510(k) clearance is a prerequisite for sales of this category of medtech products in the U.S.

LinkMed’s ownership stake in SACS Medical is 43 percent.

For more information contact:
Ingemar Lagerlöf, CEO LinkMed
Tel. +46 8 508 939 93